Havn Life Sciences announces closing of C$11.5 million Bought Deal Financing Post published:January 7, 2021 Post category:Press Release
MindMed Closes Upsized Financing of CAD $92.1m (USD $72.7m) to Meet High Investor Demand Post published:January 7, 2021 Post category:Press Release
Red Light Holland Announces $5 Million Bought Deal Equity Financing Post published:January 7, 2021 Post category:Press Release
Mydecine Innovations Group Shares Intellectual Property Update Post published:January 7, 2021 Post category:Press Release
Field Trip Health Ltd. Announces Participation in a MAPS-sponsored Multi-Site Study of MDMA-Assisted Therapy to Treat Eating Disorders Post published:January 7, 2021 Post category:Press Release
Psychedelics Research Review: December 2020 Post published:January 7, 2021 Post category:Psychedelics Research Review
Tryp Therapeutics Appoints Dr. William K. Schmidt to Its Scientific Advisory Board Post published:January 7, 2021 Post category:Press Release
NeonMind Appoints Trevor Millar as Chief Psychedelic Officer Post published:January 7, 2021 Post category:Press Release
CYBIN Provides Update on Patent Filings & Development of Therapeutics Program Post published:January 6, 2021 Post category:Press Release
Alberta Palliative Patient Successfully Undergoes First Legal Psychedelic-Assisted Therapy in Alberta, Initial Outcomes Exceed Expectations Post published:January 6, 2021 Post category:Press Release